Correlation Between Pfizer and ProShares UltraShort

Can any of the company-specific risk be diversified away by investing in both Pfizer and ProShares UltraShort at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and ProShares UltraShort into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Pfizer Inc and ProShares UltraShort MidCap400, you can compare the effects of market volatilities on Pfizer and ProShares UltraShort and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of ProShares UltraShort. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and ProShares UltraShort.

Diversification Opportunities for Pfizer and ProShares UltraShort

0.54

Correlation Coefficient

Pfizer  ProShares UltraShort

Very weak diversification

The 3 months correlation between Pfizer and ProShares is 0.54. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and ProShares UltraShort MidCap400 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ProShares UltraShort and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with ProShares UltraShort. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ProShares UltraShort has no effect on the direction of Pfizer i.e., Pfizer and ProShares UltraShort go up and down completely randomly.

Pair Corralation between Pfizer and ProShares UltraShort

Considering the 90-day investment horizon Pfizer Inc is expected to under-perform the ProShares UltraShort. But the stock apears to be less risky and, when comparing its historical volatility, Pfizer Inc is 1.45 times less risky than ProShares UltraShort. The stock trades about -0.05 of its potential returns per unit of risk. The ProShares UltraShort MidCap400 is currently generating about -0.02 of returns per unit of risk over similar time horizon. If you would invest  1,225  in ProShares UltraShort MidCap400 on October 24, 2024 and sell it today you would lose (350.00) from holding ProShares UltraShort MidCap400 or give up 28.57% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Pfizer Inc  vs.  ProShares UltraShort MidCap400

Pfizer Inc

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Pfizer Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unsteady performance, the Stock's technical and fundamental indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.

ProShares UltraShort

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days ProShares UltraShort MidCap400 has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest inconsistent performance, the Etf's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the ETF investors.

Pair Trading with Pfizer and ProShares UltraShort

The main advantage of trading using opposite Pfizer and ProShares UltraShort positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, ProShares UltraShort can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ProShares UltraShort will offset losses from the drop in ProShares UltraShort's long position.

The idea behind Pfizer Inc and ProShares UltraShort MidCap400 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.